NR
Nina Rajiv Gandhi
About Nina Rajiv Gandhi
Data last updated:
Nina Rajiv Gandhi is an Alternate Director at Hester Biosciences Limited (since 2016), Director at Hester Diagnostics Private Limited (since 1998) and Director at Texas Lifesciences Private Limited (since 2017), and holds 3 more current directorships. The companies operate in Pharma, Healthcare and Packaging. The 5 current companies with reported revenue have a combined latest revenue of ₹470 Cr; the largest is Hester Biosciences Limited at ₹315 Cr (FY 2025). Earlier, Nina Rajiv Gandhi was a Director at Gujarat Airconnect Private Limited (2017–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Alternate Director | 07 May 2016 | 1987 | ₹315 Cr (FY 2025) | Active | |
| Director | 09 Jun 1998 | 1998 | ₹120 Cr (FY 2025) | Active | |
| Director | 06 Jun 2017 | 2017 | ₹28.60 Cr (FY 2025) | Active | |
| Director | 30 Sep 2014 | 2007 | ₹5.57 Cr (FY 2025) | Active | |
| Director | 13 Aug 1991 | 1991 | ₹50.7 Lakh (FY 2025) | Active | |
| Designated Partner | 21 Mar 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jan 2017 | 2010 | ₹16.2 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nina Rajiv Gandhi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nina Rajiv Gandhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nina Rajiv Gandhi
Nina Rajiv Gandhi currently holds 6 directorships: Hester Biosciences Limited (Alternate Director, since 07 May 2016, revenue ₹315 Cr (FY 2025)); Hester Diagnostics Private Limited (Director, since 09 Jun 1998, revenue ₹120 Cr (FY 2025)); Texas Lifesciences Private Limited (Director, since 06 Jun 2017, revenue ₹28.60 Cr (FY 2025)); Gujarat Polyplast Private Limited (Director, since 30 Sep 2014, revenue ₹5.57 Cr (FY 2025)); Biolink Healthcare Limited (Director, since 13 Aug 1991, revenue ₹50.7 Lakh (FY 2025)); and 1 more.
Nina Rajiv Gandhi was first appointed on 13 Aug 1991 as Director at Biolink Healthcare Limited. The most recent appointment on record is 06 Jun 2017 at Texas Lifesciences Private Limited.
The 5 current companies of Nina Rajiv Gandhi that report revenue have a combined latest revenue of ₹470 Cr: Hester Biosciences Limited ₹315 Cr (FY 2025); Hester Diagnostics Private Limited ₹120 Cr (FY 2025); Texas Lifesciences Private Limited ₹28.60 Cr (FY 2025); Gujarat Polyplast Private Limited ₹5.57 Cr (FY 2025); Biolink Healthcare Limited ₹50.7 Lakh (FY 2025).
Nina Rajiv Gandhi held 1 earlier board appointment: Gujarat Airconnect Private Limited (Director, 16 Jan 2017 to 04 Sep 2019).
The current boards of Nina Rajiv Gandhi's companies include Ameetkumar Hiranyakumar Desai (Hester Biosciences Limited), Anil Jain (Hester Biosciences Limited), Ashish Dinesh Desai (Hester Biosciences Limited), Ashok Bhadakal Bhimarao (Hester Biosciences Limited), Bhupendra Vithaldas Gandhi (Hester Biosciences Limited), Jatin Yagneshbhai Trivedi (Hester Biosciences Limited), among others.